Results 201 to 210 of about 2,882,726 (279)

Nocturnal peak in cardiac baroreflex effectiveness aligns with nocturnal trough in systolic blood pressure in young healthy adults: Possible circadian effects

Physiological Reports, Volume 14, Issue 17, September 2026.
Abstract We tested whether there is a circadian variation in baroreflex function measured as sensitivity and effectiveness, and whether it aligned with circadian variations in systolic blood pressure (BP). Eleven healthy adults (24 ± 2 years; 4 males and 7 females) completed a 30‐h circadian protocol incorporating five recurring, identical, 6‐h cycles ...
Leandro C. Brito, Megan L. Jones, Nicole Chaudhary, Steven A. Shea, Saurabh S. Thosar   +4 more
wiley   +1 more source

E-cigarettes versus combination nicotine replacement therapy following a recent failed quit attempt: a pragmatic randomized trial through state tobacco quitlines. [PDF]

Lancet Reg Health Am
Wagener TL, Hinton A, Brasky TM, Cho YJ, Beebe LA, Businelle MS, Carpenter MJ, Hart J, Vickerman KA.   +8 more
europepmc   +1 more source

Tobacco, electronic nicotine delivery system, nicotine replacement therapy, and cannabinoid use during pregnancy: A descriptive cross-sectional survey. [PDF]

PLoS One
Kandhasamy S, Baggio S, Mathis J, Mattmann Y, Maisonneuve E, Auer R, Panchaud A, Jenkinson SP, Schoeni A.   +8 more
europepmc   +1 more source

Real-World Effectiveness of Nicotine Replacement Therapy Sampling in Chinese Women of a Sex-Specific Smoking Cessation Program in Hong Kong, China. [PDF]

Nicotine Tob Res
Chen H, Luk TT, Guo Z, Yip AON, Cheung YTD, Chan SSC, Lam TH, Wang MP.   +7 more
europepmc   +1 more source

Nicotine replacement therapy on the NHS [PDF]

BMJ, 1997
openaire   +2 more sources

Beliefs regarding nicotine replacement therapy among rural residing people who smoke: a step towards promoting uptake. [PDF]

Prev Med Rep
Carroll DM, Tan A, Differding M, Wackowski OA, Rubenstein D, Hatsukami DK, Noonan D, McClernon FJ.   +7 more
europepmc   +1 more source

Pharmacovigilance Study on Adverse Events of Nicotine Replacement Therapy, Bupropion, and Varenicline in Patients with Chronic Obstructive Pulmonary Disease. [PDF]

Int J Chron Obstruct Pulmon Dis
Wang YD, Wang YT, Chen HH, Bao JK, Chen SM, Chen DX.   +5 more
europepmc   +1 more source

Nicotine replacement therapy for palliation of nicotine abstinence syndrome- Is it worth?

Indian Journal of Palliative Care, 2014
openaire   +2 more sources

Corrigendum to "Perceptions of pharmacist-furnished nicotine replacement therapy among participants who smoke in California": [JAPhA, Volume 65 (2025), Issue September-October, 5102450]. [PDF]

J Am Pharm Assoc (2003)
europepmc   +1 more source